How can drug shortages be addressed? Policymakers can: 🔶 Increase transparency 🔶Quickly respond to shortages 🔶Raise awareness 🔶Encourage manufacturing Learn more: bit.ly/48OyzBg

Next up for GAP's Steering Committee spotlights: International Cancer Advocacy Network. Their mission is to assist & empower late-stage patients worldwide with cutting-edge information on anticancer drugs in clinical trials. Learn more about ICAN, International Cancer Advocacy Network: askican.org

Patients shouldn't have to pay the price of drug shortages. Supporting an efficient approval pathway, ensuring a sustainable marketplace, and incentivizing manufacturing is essential. Learn more: bit.ly/3WpUsSz

Skinny labeling is a process that allows generic drug manufacturers to seek FDA approval for uses of a drug no longer protected by patents, allowing drugs to enter the market sooner, lower costs, and more treatment options. Learn more: bit.ly/41wxDOU

User-fee programs have enabled the FDA to approve more new, generic, and biosimilar medications for 30 years now. Almost 100 first-time generic drugs are being safely approved every year, and at a faster pace than ever before Read more: bit.ly/4jzFm5y

As medicine moves forward, treatments are becoming more complex, making them harder to replicate and more expensive to access. Complex generics help close the gap by offering the same quality at a lower cost to patients. Learn more: bit.ly/4l7FPxo

Nationwide shortages of generic drugs continue to plague patients. Affordable and effective medications are key to continuity of care. Patients are looking to Washington to determine how to make generic drugs readily available once again. Learn more: bit.ly/4ku12BB

Generic drugs save the health care system billions of dollars every year and help increase access to medicine. With greater awareness and more education, generics can benefit still more patients across the country. Learn more: bit.ly/3QnhCFN

#DYK? 96% of survey respondents agreed generic drugs save patients money. Generic drugs save the health care system billions of dollars every year and help increase access to medicine. Learn more: bit.ly/4eHgiZv

The Generics Access Project works to improve accessibility, advocacy and awareness of affordable generic drugs. Learn more: bit.ly/4mbaqdt

Patient access to affordable generic drugs is critically important. The Generics Access Project advocates for policies that promote generic competition and efficient approval of these medicines. Learn more about GAP: bit.ly/4mbaqdt

DYK? Skinny labeling allows generic drugs to enter the market sooner, meaning patients can benefit from: • Lower drug prices • More treatment options • Increased competition Learn more: genericsproject.org/wp-content/upl…

Generic drugs, including complex generics, benefit the health care system by: 💸 Offering cost savings 🥼 Improving treatment access 💊 Encouraging disease management Learn more: bit.ly/3XUL6PV

Developing, testing and approving new prescription drugs is a long and expensive process. But when the FDA gets backlogged, and new medications are unnecessarily delayed, patients suffer. Learn more: bit.ly/4jzFm5y

Findings largely show that patients trust their providers and understand the value of generics, but more education on safety, manufacturing, and chemical makeup could strengthen confidence in generic medications. Learn more: bit.ly/3QnhCFN

What is a drug shortage? According to the FDA, a drug shortage occurs when demand or projected demand for a drug within the United States exceeds supply for a period of time. Learn more: bit.ly/4mN9UCY

Why do #generic drug shortages occur? Some factors include: 💹 Market structure ✖️ Regulatory complexity 🚨 Supply chain challenges ➕ Increased demand Learn more: bit.ly/45MS8s0

#DYK? Only 65% of patients know that #genericdrugs are chemically identical to their brand-name counterpart. Learn more: bit.ly/3QnhCFN

GAP focuses on improving timely patient access to #genericdrugs, promoting efficient approvals, and ensuring the FDA prioritizes unmet patient needs and listens to the patient perspective. Visit GAP's website to learn more & sign up for the newsletter: bit.ly/3MxIgb5

User-fee programs expanded affordable treatment options by helping the FDA review generic drug applications in a timely manner, as well as supporting the development of medications, devices and certain accreditations. Learn more: bit.ly/4jzFm5y